Neuronetics Inc (STIM)
3.65
-0.10
(-2.67%)
USD |
NASDAQ |
Apr 25, 10:33
Neuronetics Debt to Equity Ratio: 1.734 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.734 |
| September 30, 2023 | 0.9713 |
| June 30, 2023 | 0.8073 |
| March 31, 2023 | 0.7579 |
| December 31, 2022 | 0.6301 |
| September 30, 2022 | 0.5677 |
| June 30, 2022 | 0.5201 |
| March 31, 2022 | 0.4627 |
| December 31, 2021 | 0.4149 |
| September 30, 2021 | 0.3854 |
| June 30, 2021 | 0.3596 |
| March 31, 2021 | 0.3412 |
| December 31, 2020 | 1.358 |
| Date | Value |
|---|---|
| September 30, 2020 | 1.257 |
| June 30, 2020 | 1.168 |
| March 31, 2020 | 0.937 |
| December 31, 2019 | 0.6509 |
| September 30, 2019 | 0.5697 |
| June 30, 2019 | 0.5142 |
| March 31, 2019 | 0.4673 |
| December 31, 2018 | 0.4278 |
| September 30, 2018 | 0.3955 |
| June 30, 2018 | -0.1461 |
| March 31, 2018 | -2.879 |
| December 31, 2017 | -0.1534 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.3412
Minimum
Mar 2021
1.734
Maximum
Dec 2023
0.7582
Average
0.6301
Median
Dec 2022
Debt to Equity Ratio Benchmarks
| Delcath Systems Inc | 0.6433 |
| Star Equity Holdings Inc | 0.0309 |
| Exact Sciences Corp | 0.7517 |
| CytoSorbents Corp | 0.2167 |
| Progyny Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 115.83M |
| Total Liabilities (Quarterly) | 81.64M |
| Shareholders Equity (Quarterly) | 34.19M |
| Current Ratio | 4.734 |
| Net Debt Paydown Yield | -5.58% |